Location: Boston, MA (hybrid, 3 days on-site). Reports to the global franchise lead.
The opportunity
An established global healthcare company is building a medical aesthetics business from the ground up, preparing an aesthetics launch and extending its portfolio, with the ambition to lead the category. Chances like this are rare: the blank page of a start-up with the reach, funding and patience of a global business behind it. This role owns the programme at the centre of the build. Full accountability for an asset reaching launch, a cross-functional team to lead, and direct visibility to senior leadership from day one.
The role
You hold the programme end to end: the one person accountable for it reaching launch. You will own the integrated programme plan covering timelines, milestones, risks and budget. You will lead the cross-functional team across R&D, Regulatory, Quality, Medical and Commercial, without line authority, knowing enough in each function to steer and unblock it. You will manage external partners, from developers to manufacturers and CDMOs, holding delivery on scope, timelines, cost and quality, and bring technical and programme judgement to the assessment of future portfolio additions. You will not own the functional work itself: regulatory submissions and clinical trials sit with the functional experts.
What we are looking for
Experience leading or driving cross-functional development programmes for medical devices or injectables in a regulated environment (EU MDR, FDA or equivalent). A background in HA fillers, aesthetic injectables or comparable device-based technologies; aesthetics-adjacent and wider Class II/III device backgrounds are also considered. Experience working with external partners: manufacturers, licensors, developers, CDMOs. Breadth across functions, with enough depth in R&D, regulatory, clinical and quality to lead each without owning it. Personal ownership of a full development-to-launch arc is a strong plus, not a requirement. An advanced degree in a relevant scientific or technical discipline. Comfort building in ambiguity: the portfolio is growing and the role grows with it.
The growth
This is the first dedicated programme seat in a franchise being built from scratch, and the portfolio it serves is set to expand. For a technical or programme specialist it is the way out of the single lane: oversight of the entire process, real pull on decisions, and scope that grows as the portfolio does. The people who thrive here see five years ahead.
